Back to search

Belgium· BE-AMP-SAM589697-00

Fingolimod Mylan 0.5 mg

A fingolimod product containing fingolimod hydrochloride, registered in Belgium by Mylan Pharmaceuticals. The same ATC class is registered in 16 of our 19 countries.

ATC L04AE01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedFingolimod Mylan 0.5 mgATCL04AE01REGISTER NO.BE-AMP-SAM589697-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Fingolimod is registered in 16 of 19 countries.

Countries holding a registration under ATC L04AE01 (fingolimod), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Fingolimod · ATC L04AE01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fingolimod costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Fingolimod · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • IT Italy$27.25
  • CH Switzerland$18.53
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Fingolimod Hydrochloride
Manufacturer
Mylan Pharmaceuticals
Country
Belgium (BE)
ATC code
L04AE01
ATC class
Fingolimod
Defined daily dose
0.5 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7733272
  • be_apb
    4407664

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

584 interactions on record for fingolimod.

Graded by severity as the source publishes them — 503 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fingolimod · interactions on record

584 records

  • 503 severe
  • 77 moderate
  • 4 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fingolimod in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fingolimod products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Areleptan, Chantico
  • Bulgaria · Chantico, Inzolfi
  • Cyprus · Fingolimod Adelco, Fingolimod Remedica
  • Czechia · Areleptan, Bonaxon
  • Germany · Fingod, Fingolimod 123 Acurae Pharma
  • Denmark · Areleptan, Bonaxon
  • Estonia · Chantico, Efigalo
  • Spain · Fingolimod, Fingolimod Aurovitas
  • Finland · Fingolimod, Fingolimod Avansor
  • France · Fingolimod Arrow, Fingolimod Benta
  • United Kingdom (Northern Ireland) · Fingolimod, Fingolimod Amarox
  • Greece · Fingolimod Adelco, Fingolimod Medochemie
  • Croatia · Areleptan, Arlesias
  • Hungary · Bonaxon, Chantico
  • Ireland · Fingolimod Clonmel, Fingolimod Flynn Pharma
  • Iceland · Fingolimod, Fingolimod Accord
  • Italy · Fingolimod Aurobindo, Fingolimod Dr. Reddy’s
  • Liechtenstein · Fingolimod Accord, Fingolimod Mylan
  • Lithuania · Chantico, Efigalo
  • Luxembourg · Fingolimod Eg, Fingolimod Ratiopharm
  • Latvia · Bonaxon, Chantico
  • Malta · Fingolimod Denk, Fingolimod Remedica
  • Netherlands · Chantico, Fenoxa
  • Norway · Areleptan, Fingolimod Accord
  • Poland · Bonaxon, Chantico
  • Portugal · Bluesar, Fingolimod Bluefish
  • Romania · Fingolimod Dr. Reddys, Fingolimod Msn
  • Sweden · Areleptan, Fingolimod Amarox
  • Slovenia · Areleptan, Arlesias
  • Slovakia · Areleptan, Bonaxon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be2bee2b-0041-437b-bafb-aa87303882b5
GET /v1/drugs/be2bee2b-0041-437b-bafb-aa87303882b5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Fingolimod Mylan 0.5 mg",
  "name_fr": "Fingolimod Mylan 0.5 mg",
  "name_nl": "Fingolimod Mylan 0.5 mg",
  "amp_code": "SAM589697-00",
  "strengths": [
    "0.5000",
    "0.5000"
  ],
  "pack_count": 24,
  "substances": [
    "Fingolimod Hydrochloride",
    "Fingolimod",
    "Potassium Hydroxide",
    "Propylene Glycol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fingolimod",
  "authorisation_numbers": [
    "EU/1/21/1573/003",
    "EU/1/21/1573/004",
    "EU/1/21/1573/001",
    "EU/1/21/1573/002",
    "EU/1/21/1573/007",
    "EU/1/21/1573/008",
    "EU/1/21/1573/005",
    "EU/1/21/1573/006",
    "EU/1/21/1573/011",
    "EU/1/21/1573/012",
    "EU/1/21/1573/009",
    "EU/1/21/1573/010",
    "EU/1/21/1573/015",
    "EU/1/21/1573/016",
    "EU/1/21/1573/013",
    "EU/1/21/1573/014",
    "EU/1/21/1573/019",
    "EU/1/21/1573/020",
    "EU/1/21/1573/017",
    "EU/1/21/1573/018",
    "EU/1/21/1573/023",
    "EU/1/21/1573/024",
    "EU/1/21/1573/021",
    "EU/1/21/1573/022"
  ]
}

See everything about fingolimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.